A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

A Maulard, C Chargari, M Faron, A Alwohaibi… - Gynecologic …, 2020 - Elsevier
Objective To define a prognostic score based on pretreatment values of leucocyte, platelet
and hemoglobin in locally advanced cervical cancer (LACC). Material and methods We …
被引用次数：6 相关文章

A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

A Maulard, C Chargari, M Faron, A Alwohaibi… - Gynecologic …, 2020 - hal.science
Objective: To define a prognostic score based on pretreatment values of leucocyte, platelet
and hemoglobin in locally advanced cervical cancer (LACC). Material and methods: We …

A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.

A Maulard, C Chargari, M Faron, A Alwohaibi… - Gynecologic …, 2020 - europepmc.org
A new score based on biomarker values to predict the prognosis of locally advanced cervical
cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

A Maulard, C Chargari, M Faron… - Gynecologic …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To define a prognostic score based on pretreatment values of leucocyte, platelet
and hemoglobin in locally advanced cervical cancer (LACC). Material and methods We …

A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

A Maulard, C Chargari, M Faron… - Gynecologic …, 2020 - gynecologiconcology-online.net
Objective To define a prognostic score based on pretreatment values of leucocyte, platelet
and hemoglobin in locally advanced cervical cancer (LACC). Material and methods We …
[PDF] hal.science

[PDF][PDF] A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer

A Maulard, C Chargari, M Faron, A Alwohaibi, A Leary… - 2020 - hal.science
Results: Patients had clinical International Federation of Gynecology and Obstetrics 78
stages IB2 (n= 76), IIA (n= 13), IIB (n= 122), III (n= 18) or IVA (n= 9). We identified 79 three …